• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Infinity Pharmaceuticals Inc

+ Add to Watchlist

I3F:GR

10.327 EUR 0.440 4.45%

As of 11:41:50 ET on 10/24/2014.

Snapshot for Infinity Pharmaceuticals Inc (I3F)

Open: 10.243 Day's Range: 10.243 - 10.655 Volume: 1,635
Previous Close: 9.887 52wk Range: 6.091 - 13.186 1-Yr Rtn: +9.44%

Stock Chart for I3F

No chart data available.
  • I3F:GR 10.327
  • 1D
  • 1M
  • 1Y
9.887
Interactive I3F Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for I3F

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -1.3270
Est. PEG Ratio -
Market Cap (M EUR) 501.75
Shares Outstanding (M) 48.59
30 Day Average Volume 172
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for I3F

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for I3F

Infinity Pharmaceuticals, Inc. researches and develops cancer drugs. The Company uses small molecule drug technologies in the development of its products.

Adelene Q PerkinsChairman/President/CEODavid A RothChief Medical Officer
Vito J PalombellaChief Scientific OfficerJulian AdamsPresident:Research & Dev
More Company Profile & Key Executives for I3F

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil